Synchronization of posttranslational modifications during aging: Time is a crucial biological dimension

Annals of the New York Academy of Sciences

Volumn 1197, Issue , 2010, Pages 118-128

  Schrattenholz, André ^a   Šoškić, Vukić ^a   Groebe, Karlfried ^a  

^a PROTEOSYS AG   (Germany)

Author keywords

Differential protein quantification; Differential quantification; Posttranslational modification; Resolution; Statistical validation; Surrogate biomarkers

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; BIOLOGICAL MARKER; DOPAMINE;

AGING; APOPTOSIS; AUTOPHAGY; CELLULAR STRESS RESPONSE; CONFERENCE PAPER; DATA BASE; DOPAMINE METABOLISM; EXCITOTOXICITY; INFORMATION PROCESSING; ISOTOPE LABELING; MASS SPECTROMETRY; MATHEMATICAL MODEL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION; MOLECULAR INTERACTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TARGETING; PROTEOMICS;

EID: 77953224213     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05395.x     Document Type: Conference Paper

References (37)

1. Schrattenholz, A. & V. Soskic. 2008. What does systems biology mean for drug development? Curr. Med. Chem. 15: 1520-1528.
2. Auffray, C., Z. Chen & L.Hood. 2009. Systemsmedicine: the future of medical genomics and healthcare. Genome Med. 1: 2.
3. Simpson, K.L., A.D. Whetton & C. Dive. 2009. Quantitative mass spectrometry-based techniques for clinical use: biomarker identification and quantification. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877: 1240-1249.
4. Faca, V., H. Wang & S. Hanash. 2009. Proteomic global profiling for cancer biomarker discovery. Methods Mol. Biol. 492: 309-320.
5. Landais, P., V. Meresse & J.C. Ghislain. 2009. Evaluation and validation of diagnostic tests for guiding therapeutic decisions. Therapie 64: 187-201.
6. Hunzinger, C. et al. 2006. Comparison of different separation technologies for proteome analyses: isoform resolution as a prerequisite for the definition of protein biomarkers on the level of posttranslational modification. J. Chromatogr. A 1123: 170-181.
7. Schrattenholz, A. & K. Groebe. 2007.What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers. Electrophoresis 28: 1970-1979.
8. Matt, P., Z. Fu, Q. Fu & J.E. Van Eyk. 2008. Biomarker discovery: proteome fractionation and separation in biological samples. Physiol. Genomics 33: 12-17.
9. Groebe,K. et al. 2007. Differential proteomic profiling of mitochondria from Podospora anserina, rat and human reveals distinct patterns of age-related oxidative changes. Exp. Gerontol. 42: 887-898.
10. Soskic,V., K.Groebe&A. Schrattenholz. 2007.Nonenzymatic posttranslational protein modifications in ageing. Exp. Gerontol. 43: 247-257.
11. Hunzinger, C. et al. 2006. Comparative profiling of the mammalian mitochondrial proteome: multiple aconitase-2 isoforms including N-formylkynurenine modifications as part of a protein biomarker signature for reactive oxidative species. J. Proteome. Res. 5: 625-633.
12. Wozny, W. et al. 2007. Differential radioactive quantification of protein abundance ratios between benign and malignant prostate tissues: cancer association of annexin A3. Proteomics 7: 313-322.
13. Sommer, S. et al. 2004. Molecular analysis of homocysteic acid-induced neuronal stress. J. Proteome. Res. 3: 572-581.
14. Nicholls, D.G. 2009. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim. Biophys. Acta 1787: 1416-1424.
15. Rego, A.C. & C.R. Oliveira. 2003. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem. Res. 28: 1563-1574.
16. Emerit, J.,M. Edeas & F. Bricaire. 2004. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58: 39-46.
17. Rodriguez-Enriquez, S., L. He & J.J. Lemasters. 2004. Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int. J. Biochem. Cell Biol. 36: 2463-2472.
18. Stefanis, L. 2005. Caspase-dependent and -independent neuronal death: two distinct pathways toneuronal injury. Neuroscientist 11: 50-62.
19. Schrattenholz, A. &M. Klemm. 2007. Neuronal cell culture from human embryonic stemcells as in vitromodel for neuroprotection. ALTEX 24: 9-15.
20. Soskic, V. et al. 2008. A connection between the mitochondrial permeability transition pore, autophagy, and cerebral amyloidogenesis. J. Proteome Res. 7: 2262-2269.
21. Brazma, A. et al. 2001. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29: 365-371.
22. Taylor,C.F. et al. 2007. The minimuminformation about a proteomics experiment (MIAPE). Nat. Biotechnol. 25: 887-893.
23. Jones, A.R.&N.W. Paton. 2005. An analysis of extensible modelling for functional genomics data. BMC Bioinformatics 6: 235.
24. Kaiser, J. 2002. Proteomics. Public-private group maps out initiatives. Science 296: 827.
25. Orchard, S.,H.Hermjakob&R.Apweiler. 2003. The proteomics standards initiative. Proteomics 3: 1374-1376.
26. Qureshi, M. & A. Ivens. 2008. A software framework for microarray and gene expression object model (MAGEOM) array design annotation. BMC Genomics 9: 133.
27. Spellman, P.T. et al. 2002. Design and implementation of microarray gene expression markup language (MAGEML). Genome Biol. 3: RESEARCH0046.
28. Sarkans,U. et al. 2005. TheArrayExpress gene expression database: a software engineering and implementation perspective. Bioinformatics 21: 1495-1501.
29. Gibson, F. et al. 2008. Guidelines for reporting the use of gel electrophoresis in proteomics. Nat. Biotechnol. 26: 863-864.
30. Robin, X., C. Hoogland, R.D. Appel & F. Lisacek. 2008. MIAPEGelDB, a web-based submission tool and public repository for MIAPE gel electrophoresis documents. J. Proteomics. 71: 249-251.
31. Binz, P.A. et al. 2008. Guidelines for reporting the use of mass spectrometry informatics in proteomics. Nat. Biotechnol. 26: 862.
32. Jones, P. et al. 2006. PRIDE: a public repository of protein and peptide identifications for the proteomics community. Nucleic Acids Res. 34: D659-D663.
33. Jones, P. et al. 2008. PRIDE: new developments and new datasets. Nucleic Acids Res. 36: D878-D883.
34. Kanehisa, M. et al. 2004. The KEGG resource for deciphering the genome. Nucleic Acids Res. 32: D277-D280.
35. Schomburg, I., A. Chang & D. Schomburg. 2002. BRENDA, enzyme data andmetabolic information. Nucleic Acids Res. 30: 47-49.
36. Sauro, H.M. et al. 2003. Next generation simulation tools: the Systems Biology Workbench and BioSPICE integration. OMICS 7: 355-372.
37. Hucka, M. et al. 2003. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19: 524-531.